Company: ABUS
Filing Date: 2025-06-25
Form Type: 8-K
Source: 0001171843-25-004094
Chunk: 2

Company: Arbutus Biopharma Corp
Filing Date: 2025-06-25
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit Number      Description                                                                                                                 
  10.1 †              Termination Agreement, dated June 20, 2025, by and between Arbutus Biopharma Corporation and Qilu Pharmaceutical Co., Ltd.  
  99.1                Press Release dated June 25, 2025                                                                                           
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104                 Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                 

† Certain confidential portions of the agreement were omitted by means of marking such portions with brackets (due to the registrant customarily and actually treating such information as private or confidential and such omitted information not being material) pursuant to Item 601 of Regulation S-K promulgated by the SEC. Arbutus agrees to supplementally furnish a copy of any confidential portions to the SEC upon request.